Rigetti ended Q1 FY26 with $569 million in cash, zero debt, and revenue growth of 198.9% year-over-year. Approximately $2.7-$3.0 million of the Novera QPU order appears positioned for Q2-FY26 revenue recognition. A potential $100 million CHIPS Act investment strengthens funding capacity and supports long-term quantum development efforts.